SCHEMBL5692811

SCHEMBL5692811

CC(=O)Cc1ccc2cc(O)ccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.51
PTGS1 P23219 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
NLRP3 Q96P20 1/20 0.45
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP3A4 P08684 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
CYP1A2 P05177 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
MAOA P21397 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265881 0.82 L3MBTL1 (0.56) ALOX5NLRP3SMN1; SMN2CYP1A2KDM4E
SCHEMBL8813563 0.82 CA2 (0.63) ALOX5PTGS1AKR1C3AKR1C2NLRP3
SCHEMBL31443016 0.82 CA2 (0.63) ALOX5PTGS1AKR1C3AKR1C2NLRP3
SCHEMBL21556072 0.81 CYP1A2 (0.66) ALOX5SMN1; SMN2CYP3A4NPC1RAB9A
SCHEMBL18537208 0.81 L3MBTL1 (0.51) ALOX5PTGS1AKR1C3AKR1C2NLRP3
Methane SCHEMBL9087531 0.81 CA2 (0.61) ALOX5PTGS1AKR1C3AKR1C2NLRP3
SCHEMBL4672727 0.81 CA2 (0.64) ALOX5PTGS1AKR1C3AKR1C2NLRP3
SCHEMBL7801633 0.80 HSP90AB1 (0.58) ALOX5PTGS1AKR1C3AKR1C2NLRP3
SCHEMBL28550460 0.79 PTGS1 (0.45) PTGS1AKR1C3AKR1C2POLBSMN1; SMN2
SCHEMBL5239907 0.79 PTGS1 (0.45) PTGS1AKR1C3AKR1C2POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102316733-A HETEROCYCLIC COMPOUNDS AND METHODS OF USE INST MEDICAL W & E HALL 2012-01-11 CN disclosed
EP-1654236-A1 NAPHTHYLENE DERIVATIVES AS CYTOCHROME P450 INHIBITORS OSI Pharmaceuticals, Inc. (US) 2006-05-10 EP disclosed
WO-2005007631-A1 NAPHTHYLENE DERIVATIVES AS CYTOCHROME P450 INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2005-01-27 WO disclosed